Study reports success in treating cognitive decline and memory loss associated with Alzheimer's disease with the aid of personalized precision medicine. Read More
Advertisements
Subtle changes in thinking and memory may appear before, or in conjunction with, the development of amyloid plaques. Read More
Older mice given anti-inflammatory medication were better able to learn new tasks and became almost as adept at learning as mice half their age. Read More
Study reveals there is no link between memory decline and statin use in older adults. Additionally, no association was found between statin use and cognitive decline in those with genetic risk factors for dementia. Read More
Pernicious anemia is an autoimmune disorder associated with vitamin B12 deficiency. The condition not only affects physical health, it also has a detrimental effect on the mental health of many who suffer from the condition. Read More
A newly identified neural network in the hippocampal formation plays a critical role in memory and object-location learning. The findings are highly relevant to learning and memory disorders, including Alzheimer's disease. Read More
Mouse study reveals a clear correlation between cognitive ability in aging and presynaptic calcium levels. Read More
Middle-aged and older people who stay mentally active have a lower risk of developing mild cognitive impairment. Read More
A rare autoimmune disorder popularized by the autobiography and movie "Brain on Fire" is triggered by an attack on NMDA receptors. The disease occurs when antibodies attack NMDA receptors in the brain, leading to memory loss, intellectual changes, seizures, and death. Read More
Blocking VCAM1 increased neurogenesis, and reduced microglia reactivity in the hippocampus of older mice. Read More
Senolytic drugs administered to mice reduced senescent cells around amyloid plaques by more than 90% and decreased neuroinflammation by 50%. Mice treated with the drug combination also showed improvements in spatial memory, compared to other Alzheimer's model mice who received no treatment. The findings could have positive implications for the treatment of Alzheimer's disease in people with the condition. Read More
During sepsis, the body sheds fragments of heparan sulfate, which crossed the blood-brain barrier and enters the hippocampus. The presence of heparan sulfate in the hippocampus may cause memory loss associated with septic shock. Read More
